Elscint’s VariCam approved in Japan

Article

Japanese regulatory authorities have approved Elscint's VariCamadjustable-angle dual-head gamma camera for marketing in thatcountry. VariCam will be sold in Japan by Philips under a dealbetween the companies signed last year (SCAN 11/6/96). VariCamwill

Japanese regulatory authorities have approved Elscint's VariCamadjustable-angle dual-head gamma camera for marketing in thatcountry. VariCam will be sold in Japan by Philips under a dealbetween the companies signed last year (SCAN 11/6/96). VariCamwill be the first Elscint product marketed in Japan, accordingto president and CEO Jonathan Adereth.

VariCam will take on products from Toshiba as well as Shimadzu,which markets Picker gamma cameras. Those companies dominate theJapanese nuclear medicine market, but neither firm has a variable-anglesystem. ADAC Laboratories, which does have a variable-angle camera,is still ramping up its presence in Japan after its dual-headproducts were approved in September (SCAN 10/9/96). ADAC is representedin Japan by Sumitomo Metal Industries.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.